enGene Holdings Inc.
USD1.82
-0.10 (-5.21%)
CEO
Ronald H. W. Cooper
IPO Date
2022-02-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$1.91
Prev. Close
$1.92
Day Low
$1.82
Day High
$1.95
52W Low
$1.40
52W High
$12.25
Market Cap
$0.09B
Volume
0.80M
| 31,000 |
| $1.75 |
| 17 Jun 2026 | Glickman Richard M | director | A-Award | Acquired | 31,000 | $1.75 |
| 17 Jun 2026 | Grossman William | director, officer: Interim Chief Medical Officer | A-Award | Acquired | 31,000 | $1.75 |
| 17 Jun 2026 | Grossman William | director, officer: Interim Chief Medical Officer | A-Award | Acquired | 200,000 | $1.75 |
| 17 Jun 2026 | HASTINGS PAUL J | director | A-Award | Acquired | 31,000 | $1.75 |
| 17 Jun 2026 | Heffernan Michael Thomas | director | A-Award | Acquired | 31,000 | $1.75 |
| 17 Jun 2026 | Joustra Wouter | director | A-Award | Acquired | 31,000 | $1.75 |
| 17 Jun 2026 | Zoth Lota S. | director | A-Award | Acquired | 31,000 | $1.75 |
| 3 Feb 2026 | CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | A-Award | Acquired | 195,000 | $9.53 |